In-Vitro Diagnostics Instrument

In-Vitro Diagnostics Instrument Market by Product (Clinical Microbiology, Hematology, Hemostasis), End User (Academic & Research Institutes, Homecare, Hospitals & Diagnostic Laboratories) - Global Forecast 2024-2030

360iResearch Analyst
Want to know more about the in-vitro diagnostics instrument market or any specific requirement? Ketan helps you find what you're looking for.
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[188 Pages Report] The In-Vitro Diagnostics Instrument Market size was estimated at USD 24.18 billion in 2023 and expected to reach USD 26.23 billion in 2024, at a CAGR 8.58% to reach USD 43.04 billion by 2030.

In-Vitro Diagnostics Instrument Market
To learn more about this report, request a free PDF copy
In-vitro diagnostics (IVD) instruments are devices used to conduct tests on samples such as blood, urine, or tissue extracted from the human body. These instruments aid in detecting diseases, conditions, or infections. Some IVD instruments include blood analyzers, molecular diagnostic devices, and immunoassay systems. These devices play a crucial role in clinical decision-making and are integral components in the healthcare industry. The IVD instruments industry is driven by various factors such as the rising prevalence of chronic diseases, the geriatric population, technological advancements, and increasing awareness for early diagnosis. The growing healthcare infrastructure and the rise in personalized medicine are significant contributors to the expansion of the IVD instruments industry. Moreover, the restraints include stringent regulatory requirements, which can delay product launches, and the high cost of IVD instruments that can hinder their adoption in cost-sensitive regions. Moreover, the IVD instruments industry includes opportunities driven by technological innovations that minimize errors and enhance efficiency. The integration of artificial intelligence (AI) and machine learning in diagnostics and the untapped potential in emerging economies provides ample growth prospects for industry stakeholders. The growing preference for point-of-care testing presents another significant opportunity for the IVD industry.
In-Vitro Diagnostics Instrument Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the In-Vitro Diagnostics Instrument Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the In-Vitro Diagnostics Instrument Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the In-Vitro Diagnostics Instrument Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accelerate Diagnostics, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomérieux SA, Diasorin S.P.A., F. Hoffmann-La Roche Ltd., GenomeMe Inc., Grifols SA, Hologic, Inc., PerkinElmer Inc., Qiagen N.V., Siemens Healthineers, Sysmex Corporation, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the In-Vitro Diagnostics Instrument Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Clinical Microbiology
    • Hematology
    • Hemostasis
    • Immunochemistry
    • Molecular Diagnostics
    • Point-of-Care
    • Self-Monitoring of Blood Glucose
    • Tissue Diagnostics
  • End User
    • Academic & Research Institutes
    • Homecare
    • Hospitals & Diagnostic Laboratories

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the In-Vitro Diagnostics Instrument Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the In-Vitro Diagnostics Instrument Market?
  3. What are the technology trends and regulatory frameworks in the In-Vitro Diagnostics Instrument Market?
  4. What is the market share of the leading vendors in the In-Vitro Diagnostics Instrument Market?
  5. Which modes and strategic moves are suitable for entering the In-Vitro Diagnostics Instrument Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. In-Vitro Diagnostics Instrument Market, by Product
  7. In-Vitro Diagnostics Instrument Market, by End User
  8. Americas In-Vitro Diagnostics Instrument Market
  9. Asia-Pacific In-Vitro Diagnostics Instrument Market
  10. Europe, Middle East & Africa In-Vitro Diagnostics Instrument Market
  11. Competitive Landscape
  12. Competitive Portfolio
  13. List of Figures [Total: 20]
  14. List of Tables [Total: 206]
  15. List of Companies Mentioned [Total: 15]
Frequently Asked Questions
  1. How big is the In-Vitro Diagnostics Instrument Market?
    Ans. The Global In-Vitro Diagnostics Instrument Market size was estimated at USD 24.18 billion in 2023 and expected to reach USD 26.23 billion in 2024.
  2. What is the In-Vitro Diagnostics Instrument Market growth?
    Ans. The Global In-Vitro Diagnostics Instrument Market to grow USD 43.04 billion by 2030, at a CAGR of 8.58%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.